CD3-directed Antibody Interactions [MoA] class drugs

5 results

  • columvi - glofitamab concentrate

    (Glofitamab)
    Genentech, Inc.
    Columvi treats adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL, NOS) or large B-cell lymphoma arising from follicular lymphoma, after two or more prior lines of systemic therapy.
    Medication Details
    Drug Interactions

  • epkinly - epcoritamab - bysp injection, solution

    (Epcoritamab-Bysp)
    Genmab Us, Inc.
    Epkinly treats adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma after 2+ prior therapies. Also indicated for relapsed or refractory follicular lymphoma (FL), with lenalidomide and rituximab or as monotherapy after 2+ prior therapies.
    Medication Details
    Drug Interactions

  • tzield - teplizumab - mzwv injection

    (Teplizumab-Mzwv)
    Provention Bio, Inc.
    Tzield delays the onset of Stage 3 type 1 diabetes in adults and children 1 year and older with Stage 2 T1D. It also delays the decline in endogenous insulin production in pediatric patients aged 8 to 17 years recently diagnosed with Stage 3 T1D.
    Medication Details
    Drug Interactions